COMMUNIQUÉS West-GlobeNewswire

Teladoc Health Reports First Quarter 2024 Results
25/04/2024
PURCHASE, NY, April 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended March 31, 2024 (“First [...]
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024
25/04/2024
SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024. "Accolade has built a rare healthcare [...]
Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering
25/04/2024
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
25/04/2024
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced a proposed underwritten public offering of shares of its common stock and accompanying common stock warrants to [...]
Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report
25/04/2024
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period [...]
Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel Chemically Diverse Macrocycles
25/04/2024
– Company creating de novo designed macrocycles with enhanced efficacy that precisely target disease biology – Vilya’s privileged macrocycles have the potential to be applied across broad therapeutic areas, addressing [...]
CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners
25/04/2024
CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners CARBIOS’ first plant is also a world first using revolutionary enzymatic depolymerization technology, marking a major [...]
CARBIOS pose la première pierre de son usine de biorecyclage du PET, une première mondiale, avec ses partenaires
25/04/2024
CARBIOS pose la première pierre de son usine de biorecyclage du PET, une première mondiale, avec ses partenaires Cette première usine de CARBIOS est aussi une première mondiale utilisant la technologie révolutionnaire [...]
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
25/04/2024
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – April 25, 2024 – 07:00 PM CET (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today [...]
Guerbet : Chiffre d’affaires du 1er trimestre 2024.
25/04/2024
Chiffre d’affaires du 1 er trimestre 2024 Activité trimestrielle Chiffre d’affaires : 194,3 M€, en hausse de 8,8% à TCC 1 Une croissance toujours particulièrement soutenue en Asie (+26,8% à TCC) et en zone Amériques (+ [...]
Guerbet : Q1 2024 revenue.
25/04/2024
Q1 2024 revenue Quarterly activity Revenue: €194.3m, up 8.8% at CER 1 Growth remains particularly strong in Asia (+26.8% at CER) and the Americas (+20.1% at CER); the EMEA region (-6.2% at CER) was temporarily impacted [...]
Ibogaine Treatment for Borderline Personality Disorder Launched by Ibogaine By David Dardashti
25/04/2024
New Protocol Developed to Provide Holistic, Compassionate Treatment MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce the launch of a unique therapy protocol designed to provide [...]
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
25/04/2024
HOUSTON, TEXAS, April 25, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market (“Nasdaq”) on April [...]
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
25/04/2024
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug [...]
RS BioTherapeutics Adds Jane Wright-Mitchell, Pharm.D., J.D. to Business Advisory Board
25/04/2024
Ms. Wright-Mitchell to serve as fractional General Counsel and Compliance Advisor CUMBERLAND, Md., April 25, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
25/04/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS 25 APRIL 2024 at 16.30 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
25/04/2024
Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82% 690 subjects analyzed including previously [...]
Using AI to Improve Diagnosis of Rare Genetic Disorders
25/04/2024
HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) -- Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to make the process [...]
GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
25/04/2024
Live webcast on Wednesday, May 1 st at 3:00 PM ET LA JOLLA, CA, April 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of [...]

Pages